Acadian Asset Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-67,156
| Closed | -$604K | – | 2081 |
|
|
2021
Q2 | $604K | Buy |
67,156
+18,615
| +38% | +$167K | ﹤0.01% | 1083 |
|
|
2021
Q1 | $515K | Buy |
48,541
+45,898
| +1,737% | +$487K | ﹤0.01% | 1182 |
|
|
2020
Q4 | $33K | Buy |
+2,643
| New | +$33K | ﹤0.01% | 2047 |
|
|
2019
Q1 | – | Sell |
-3,576
| Closed | -$13K | – | 2070 |
|
|
2018
Q4 | $13K | Hold |
3,576
| – | – | ﹤0.01% | 1592 |
|
|
2018
Q3 | $22K | Buy |
3,576
+1,152
| +48% | +$7.09K | ﹤0.01% | 1504 |
|
|
2018
Q2 | $18K | Buy |
+2,424
| New | +$18K | ﹤0.01% | 1537 |
|
|
2017
Q4 | – | Sell |
-2,265
| Closed | -$26K | – | 1696 |
|
|
2017
Q3 | $26K | Hold |
2,265
| – | – | ﹤0.01% | 1180 |
|
|
2017
Q2 | $22K | Buy |
2,265
+480
| +27% | +$4.66K | ﹤0.01% | 1240 |
|
|
2017
Q1 | $21K | Buy |
+1,785
| New | +$21K | ﹤0.01% | 1364 |
|
|
2016
Q4 | – | Sell |
-4,951
| Closed | -$161K | – | 1793 |
|
|
2016
Q3 | $161K | Sell |
4,951
-12,993
| -72% | -$423K | ﹤0.01% | 996 |
|
|
2016
Q2 | $330K | Buy |
17,944
+18
| +0.1% | +$331 | ﹤0.01% | 842 |
|
|
2016
Q1 | $299K | Sell |
17,926
-993
| -5% | -$16.6K | ﹤0.01% | 848 |
|
|
2015
Q4 | $587K | Buy |
+18,919
| New | +$587K | ﹤0.01% | 786 |
|